Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 13 January

Jessica Amir
January 13, 2021

Morning Bell 12 January

Jessica Amir
January 12, 2021

Morning Bell 11 January

Jessica Amir
January 11, 2021

Morning Bell 8 January

Paulina Peters
January 8, 2021

Morning Bell 7 January

Paulina Peters
January 7, 2021

Morning Bell 6 January

Paulina Peters
January 6, 2021

Morning Bell 5 January

Jessica Amir
January 5, 2021

Morning Bell 4 January

Jessica Amir
January 4, 2021

Morning Bell 30 December

Jessica Amir
December 30, 2020

Morning Bell 29 December

Jessica Amir
December 29, 2020

Morning Bell 24 December

Jessica Amir
December 24, 2020